Glooko, a global integrated digital health company connecting patients, providers, biopharma and medical device partners, today announced that it has secured a $100 million Series F financing. The Company's Board of Directors also announced the appointment of Mike Alvarez as Chief Executive Officer.

The financing round, led by Georgian, with investments from Health Catalyst Capital, Canaan and other investors and business partners, will support Glooko's continued growth and product expansion in expert data insights, device integrations, clinical research and chronic condition support for healthcare providers around the world.

Glooko improves health outcomes of people with chronic conditions through its personalized, intelligent, connected care and life sciences platform. Our proven technologies make lives better by revolutionizing the connection between patients and providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials. More than 4.4 million people around the world with diabetes have used the Glooko platform.